Friday December 6, 2019

Scientists Facilitate The Regulatory Process For Herbal Drugs

A 2017 report by the Confederation of Indian Industry (CII) predicts that the biosimilars market in India, that is currently worth about Rs 15,000 crore, is expected to cross the staggering Rs 2,50,000 crore-mark by 2030.

0
//
drugs
Documentation and characterisation of Indian herbal drugs and phytopharmaceuticals will lead to a significant usage and their export. Pixabay

Council of Scientific and Industrial Research’s constituent laboratory, the Centre for Cellular and Molecular Biology (CSIR-CCMB), Hyderabad, and the Indian Pharmacopeia Commission (IPC), Ghaziabad, have joined hands to facilitate the regulatory process for biosimilars and herbal drugs, as per a statement here on Sunday.

The scope of the memorandum of understanding (MoU) signed between CSIR-CCMB and the IPC is the development of biopharmaceutical reference standards and impurities therein, development of monographs for important Monoclonal Antibodies and identification of herbal drugs based on DNA Barcode analysis, a CCMB statement said.

Use of biologics – biological products that function as drugs against diseases – also known as biosimilars, are expanding their presence rapidly in the healthcare sector, including in India.

lab

Scientific validation and characterization of herbal drugs will not only help authentication of such drugs but also will bring credibility for this industry, the CCMB added. Pixabay

A 2017 report by the Confederation of Indian Industry (CII) predicts that the biosimilars market in India, that is currently worth about Rs 15,000 crore, is expected to cross the staggering Rs 2,50,000 crore-mark by 2030.

Emergence of biopharmaceutical drugs as a preferred choice for therapy over conventional pharma drugs, requires concerted efforts by various sectors within the country towards production, characterisation and validation of indigenously developed products, the CCMB said.

The agreement was signed by CSIR-CCMB Director Rakesh Mishra and IPC’s Secretary-cum-Scientific Director G.N. Singh.

This collaboration, which has come into force with immediate effect, is very important in the current scenario owing to the increase in use of therapeutic proteins and herbal drugs for various diseases, the statement said.

scientist
Use of biologics – biological products that function as drugs against diseases – also known as biosimilars, are expanding their presence rapidly in the healthcare sector, including in India. Pixabay

Documentation and characterisation of Indian herbal drugs and phytopharmaceuticals will lead to a significant usage and their export.

Also Read: When You Engage in ‘Hedonic Consumption’? Read Here To Find Out

This collaborative project will be executed at par with pharmacopeia standards of other countries, it said.

Scientific validation and characterization of herbal drugs will not only help authentication of such drugs but also will bring credibility for this industry, the CCMB added. (IANS)

Next Story

Flipkart Brings First Nokia-branded Smart TV in India: Report

The visuals of the TV are bolstered with "MEMC" technology, which eliminates blurs and judders for a screen shift devoid of lags, thus, offering better picture definition

0
Flipkart Buys Back Shares Worth $350 mn.
New e-commerce norms to impact e-tailers: Flipkart. IANS

Flipkart on Thursday launched the Nokia Smart TV in India as part of their strategic partnership. Priced at Rs 41,999, the Nokia-branded smart TV is currently available in a 55-inch variant and features “Sound by JBL”.

The smart TV will be available on the e-commerce platform starting December 10 and the firm will expand the line up of 4K variants in the coming months.

“The acoustics of the Nokia Smart TV has been engineered by JBL, which will let customers experience clear vocal tones and minimal harmonic distortion. True to JBL’s brand recall, the Nokia Smart TV will also enjoy deep bass tones, typically popular with Indian audiences,” the company said in a statement.

Notably, this is the first time that JBL is extending its audio expertise in television space in India.

The TV is powered by 24 watt built-in speakers, “DTS TruSurround” and Dolby Audio to enhance the overall audio experience.

Flipkart will provide complete TV protection for Nokia-branded smart TVs, which is available at a launch price of Rs 999.

Flipkart, Nokia
Flipkart earlier entered into a strategic partnership with Nokia to launch Nokia smart TVs in India. Wikimedia Commons

The programme gives consumers a coverage of three years against manufacturing defects and accidental damages, along with a guaranteed buyback value at the end of three years.

The Nokia Smart TV offers intelligent dimming that helps produce deeper blacks through accurate backlight control and a wide colour gamut.

It comes with the Android 9.0 Operating System (OS) that will allow users access a host of apps on the Android TV Play Store.

Also Read: Sony Unveils Alpha 9 II Camera in India for Rs 3,99,990

It sports a quad-core processor and 2.25GB RAM and 16GB ROM.

The visuals of the TV are bolstered with “MEMC” technology, which eliminates blurs and judders for a screen shift devoid of lags, thus, offering better picture definition. (IANS)